UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

NOTICE OF EFFECTIVENESS

Effective Date:November 18, 2022
Form:S-3
CIK:0001840233
Company Name:Xilio Therapeutics, Inc.
File Number:333-268264
Xilio Therapeutics (NASDAQ:XLO)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Xilio Therapeutics Charts.
Xilio Therapeutics (NASDAQ:XLO)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Xilio Therapeutics Charts.